Picture of Mithra Pharmaceuticals SA logo

MITRA — Mithra Pharmaceuticals SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Mithra Gets EUR 1.25 Million Payment From Fuji Pharma Under Estelle® Licensing Agreement

Aug 3 (Reuters) - Mithra Pharmaceuticals SA  MITRA.BR :
    * MITHRA RECEIVES EUR 1.25 MILLION MILESTONE PAYMENT FROM
FUJI
PHARMA UNDER ESTELLE® LICENSING AGREEMENT
    * RELATES TO COMPLETION OF INTERIM CLINICAL STUDY REPORTS OF
PHASE
3 TRIALS IN PATIENTS WITH DYSMENORRHEA OR ENDOMETRIOSIS
    * MARKS STRONG PROGRESS IN 2016 AGREEMENT AND FURTHER BOOSTS
MITHRA CASH POSITION
    * MITHRA ELIGIBLE FOR REVENUE FROM SUPPLY OF MANUFACTURED
PRODUCT
POST-COMMERCIALIZATION

Source text for Eikon:  ID:nGNE6kBkmB 
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))

Recent news on Mithra Pharmaceuticals SA

See all news